PURPOSE: Screening can increase early detection and reduce rates of advanced-stage cancer. Uninsured patients have been shown to have lower rates of screening. Previous studies have shown that uninsured patients and patients with Medicaid present with more advanced stages of cancer. The aim of this study was to measure the effect of insurance status in the setting of a safety-net hospital. METHODS: Patients in our tumor registry with a diagnosis of breast or colorectal cancer between 2001 and 2010 were included. On the basis of their insurance status, they were divided into the following groups: Medicaid, Medicare, Medicare age < 65 years, commercial, uninsured, and unknown. Cancer stage was recorded for each patient, with stages III and IV considered advanced disease. The primary end point was the rate of advanced disease in each patient group. RESULTS: A total of 910 patients were included in the study: 836 (91.9%) insured, 54 (5.9%) uninsured, and 20 (2.2%) unknown. Of the insured patients, 301 (36.0%) had Medicaid. Two hundred thirty-seven (30.7%) of 836 insured patients had advanced disease, compared with 27 (50.0%) of 54 uninsured patients (odds ratio, 1.63; P = .003). Of patients with Medicaid, 83 (27.6%) of 301 had advanced disease, which was not statistically different from patients with other insurance. CONCLUSION: In a safety-net hospital, patients with Medicaid had rates of advanced-stage cancer similar to those in patients with other types of insurance. However, patients with no insurance had significantly higher rates of advanced disease. This has significant ramifications in view of the new health care law, which will convert many patients from being uninsured to having Medicaid.
PURPOSE: Screening can increase early detection and reduce rates of advanced-stage cancer. Uninsured patients have been shown to have lower rates of screening. Previous studies have shown that uninsured patients and patients with Medicaid present with more advanced stages of cancer. The aim of this study was to measure the effect of insurance status in the setting of a safety-net hospital. METHODS:Patients in our tumor registry with a diagnosis of breast or colorectal cancer between 2001 and 2010 were included. On the basis of their insurance status, they were divided into the following groups: Medicaid, Medicare, Medicare age < 65 years, commercial, uninsured, and unknown. Cancer stage was recorded for each patient, with stages III and IV considered advanced disease. The primary end point was the rate of advanced disease in each patient group. RESULTS: A total of 910 patients were included in the study: 836 (91.9%) insured, 54 (5.9%) uninsured, and 20 (2.2%) unknown. Of the insured patients, 301 (36.0%) had Medicaid. Two hundred thirty-seven (30.7%) of 836 insured patients had advanced disease, compared with 27 (50.0%) of 54 uninsured patients (odds ratio, 1.63; P = .003). Of patients with Medicaid, 83 (27.6%) of 301 had advanced disease, which was not statistically different from patients with other insurance. CONCLUSION: In a safety-net hospital, patients with Medicaid had rates of advanced-stage cancer similar to those in patients with other types of insurance. However, patients with no insurance had significantly higher rates of advanced disease. This has significant ramifications in view of the new health care law, which will convert many patients from being uninsured to having Medicaid.
Authors: R G Roetzheim; N Pal; C Tennant; L Voti; J Z Ayanian; A Schwabe; J P Krischer Journal: J Natl Cancer Inst Date: 1999-08-18 Impact factor: 13.506
Authors: Sarah M Lyon; Nicole M Benson; Colin R Cooke; Theodore J Iwashyna; Sarah J Ratcliffe; Jeremy M Kahn Journal: Am J Respir Crit Care Med Date: 2011-10-01 Impact factor: 21.405
Authors: Susan A Sabatino; Ralph J Coates; Robert J Uhler; Nancy Breen; Florence Tangka; Kate M Shaw Journal: Med Care Date: 2008-07 Impact factor: 2.983
Authors: Anthony S Robbins; Alexandre L Pavluck; Stacey A Fedewa; Amy Y Chen; Elizabeth M Ward Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: Jacob Y Shin; Ja Kyoung Yoon; Aaron K Shin; Philip Blumenfeld; Miranda Mai; Aidnag Z Diaz Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-09-01 Impact factor: 6.223
Authors: David N Hanna; Muhammad O Ghani; Andrew Hermina; Alexander Mina; Christina E Bailey; Kamran Idrees; Deepa Magge Journal: Ann Surg Oncol Date: 2021-08-25 Impact factor: 4.339
Authors: Sarah C Markt; Carlos A Lago-Hernandez; Rowan E Miller; Brandon A Mahal; Brandon Bernard; Laurence Albiges; Lindsay A Frazier; Clair J Beard; Alexi A Wright; Christopher J Sweeney Journal: Cancer Date: 2016-08-08 Impact factor: 6.860
Authors: Lindsey A Jones; Katherine C Brewer; Leslie R Carnahan; Jennifer A Parsons; Blase N Polite; Carol Estwing Ferrans; Richard B Warnecke; Garth H Rauscher Journal: Public Health Rep Date: 2021-03-31 Impact factor: 2.792
Authors: Lynn M VanderWielen; Allison A Vanderbilt; Steven H Crossman; Sallie D Mayer; Alexander S Enurah; Samuel S Gordon; Melissa K Bradner Journal: Med Educ Online Date: 2015-04-21
Authors: Sharon Hensley Alford; Steven Leadbetter; Juan L Rodriguez; Nikki A Hawkins; Lawrence E Scholl; Lucy A Peipins Journal: Prev Med Rep Date: 2014-11-28